SCHEMBL3950440

SCHEMBL3950440

C=C(C)C(=O)OCCOC(=O)OCc1ccccc1

nearest known ligand 0.54

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 5/20 0.54
LMNA P02545 2/20 0.45
SMN1; SMN2 Q16637 1/20 0.45
TDP1 Q9NUW8 5/20 0.45
MAPK1 P28482 2/20 0.45
L3MBTL1 Q9Y468 2/20 0.45
SLC6A2 P23975 1/20 0.45
SLC6A3 Q01959 1/20 0.45
KMT2A Q03164 1/20 0.45
THRB P10828 1/20 0.45
POLB P06746 1/20 0.43
APEX1 P27695 1/20 0.43
HTT P42858 1/20 0.43
CYP3A4 P08684 1/20 0.42
TSHR P16473 1/20 0.42
RAB9A P51151 1/20 0.42
HCAR2 Q8TDS4 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8452502 0.88 ALDH1A1 (0.54) ALDH1A1LMNASMN1; SMN2TDP1MAPK1
SCHEMBL13234389 0.87 ALDH1A1 (0.66) ALDH1A1LMNASMN1; SMN2TDP1MAPK1
SCHEMBL13234388 0.87 ALDH1A1 (0.66) ALDH1A1LMNASMN1; SMN2TDP1MAPK1
SCHEMBL13234386 0.87 ALDH1A1 (0.66) ALDH1A1LMNASMN1; SMN2TDP1MAPK1
SCHEMBL13234425 0.87 ALDH1A1 (0.66) ALDH1A1LMNASMN1; SMN2TDP1MAPK1
SCHEMBL13234390 0.87 ALDH1A1 (0.66) ALDH1A1LMNASMN1; SMN2TDP1MAPK1
SCHEMBL13234404 0.87 ALDH1A1 (0.66) ALDH1A1LMNASMN1; SMN2TDP1MAPK1
SCHEMBL13234392 0.87 ALDH1A1 (0.66) ALDH1A1LMNASMN1; SMN2TDP1MAPK1
SCHEMBL13234396 0.87 ALDH1A1 (0.66) ALDH1A1LMNASMN1; SMN2TDP1MAPK1
SCHEMBL7878587 0.87 ALDH1A1 (0.66) ALDH1A1LMNASMN1; SMN2TDP1MAPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9351917-B2 Hair composition with improved rheology CONOPCO, INC. (US) 2016-05-31 US disclosed
US-7498394-B2 (Meth)acrylic and (meth)acrylamide monomers, polymerizable compositions, and polymers obtained THE REGENTS OF THE UNIVERSITY OF COLORADO (US) 2009-03-03 US disclosed
US-7498394-B2 (Meth)acrylic and (meth)acrylamide monomers, polymerizable compositions, and polymers obtained THE REGENTS OF THE UNIVERSITY OF COLORADO (US) 2009-03-03 US disclosed
US-7498394-B2 (Meth)acrylic and (meth)acrylamide monomers, polymerizable compositions, and polymers obtained THE REGENTS OF THE UNIVERSITY OF COLORADO (US) 2009-03-03 US disclosed
US-20060252900-A1 (Meth)arcrylic and (meth)acrylamide monomers, polymerizable compositions, and polymers obtained REGENTS OF THE UNIVERSITY OF COLORADO, THE 2006-11-09 US disclosed
WO-2004077511-A2 (METH)ACRYLIC AND (METH)ACRYLAMIDE MONOMERS, POLYMERIZABLE COMPOSITIONS, AND POLYMERS OBTAINED THE REGENTS OF THE UNIVERSITY OF COLORADO (US) 2004-09-10 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060252900-A1 (Meth)arcrylic and (meth)acrylamide monomers, polymerizable compositions, and polymers obtained MMAB, MAT1A, MAT2A ALDH1A1 396/4885LMNA 4478/4885SMN1; SMN2 2169/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.